Medinotec (MDNC) Liabilities and Shareholders Equity (2022 - 2026)

Medinotec has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity changed 0.06% year-over-year to $6.8 million; the trailing twelve-month figure through Feb 2026 stood at $27.4 million (up 25.94% YoY), and the FY2026 full-year result was $6.8 million, changed 0.06% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $6.8 million, down from $6.9 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $7.4 million in Q2 2025, with the low at $1.3 million in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $5.2 million across 5 years, with a median of $5.1 million in 2022.
• The largest YoY upside for Liabilities and Shareholders Equity was 239.4% in 2023 against a maximum downside of 21.61% in 2023.
• Medinotec's Liabilities and Shareholders Equity stood at $5.1 million in 2022, then slipped by 21.61% to $4.0 million in 2023, then surged by 34.34% to $5.4 million in 2024, then gained by 27.79% to $6.9 million in 2025, then slipped by 0.58% to $6.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $6.8 million (Q1 2026), $6.9 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.